Ubs Group Ag Nls Pharmaceutics Ltd. Call Options Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NLSP
# of Institutions
10Shares Held
8.53MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA5.75MShares$23.9 Million0.04% of portfolio
-
Armistice Capital, LLC New York, NY2.31MShares$9.59 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il136KShares$565,5200.0% of portfolio
-
Jane Street Group, LLC New York, NY43.7KShares$181,2380.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny21.8KShares$90,3740.0% of portfolio
About NLS Pharmaceutics Ltd.
- Ticker NLSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,349,900
- Market Cap $122M
- Description
- NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, suc...